Central clinical database of the Collaborative Research Centre's INF project (CRC/TRR295) ReTune to integrate the clinical core dataset

Charité Universitätsmedizin Berlin / Klinik für Neurologie mit Experimenteller Neurologie Sektion Bewegungsstörungen und Neuromodulation0 sites632 target enrollmentMay 12, 2023

ConditionsPatients with movement disorders Parkinson's disease,tremor, dystonia (G20-G26)

Overview

Phase: Not Applicable
Intervention: Not specified
Conditions: Patients with movement disorders Parkinson's disease,tremor, dystonia (G20-G26)
Sponsor: Charité Universitätsmedizin Berlin / Klinik für Neurologie mit Experimenteller Neurologie Sektion Bewegungsstörungen und Neuromodulation
Enrollment: 632
Status: Recruiting
Last Updated: last year

Overview Investigators Eligibility Criteria Outcomes Similar Trials

Overview

Brief Summary

No summary available.

Registry

who.int

Start Date

May 12, 2023

End Date

TBD

Last Updated

last year

Study Type

Observational

Sex

All

Investigators

Sponsor

Charité Universitätsmedizin Berlin / Klinik für Neurologie mit Experimenteller Neurologie Sektion Bewegungsstörungen und Neuromodulation

Eligibility Criteria

Inclusion Criteria

•All patients are eligible for inclusion who: \#1 Have been included in a corresponding study of a subproject of TR 295 and have consented to data transfer to the central clinical database as part of inclusion in the respective study.
•OR \#2 Patients with movement disorders Parkinson's disease, tremor, dystonia (G20\-G26: Extrapyramidal diseases and movement disorders) who are receiving DBS treatment as part of their therapy and who have consented to inclusion in the central clinical database. OR \#3 Patient:s with movement disorders Parkinson's disease, tremor, dystonia (G20\-G26: Extrapyramidal diseases and movement disorders) who are eligible for DBS treatment as part of their therapy but have not opted for DBS treatment and have consented to inclusion in the central clinical database (control group).